AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 196 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,000 | -96.3% | 1,000 | -92.4% | 0.00% | -100.0% |
| Q4 2019 | $161,000 | +7950.0% | 13,200 | +6500.0% | 0.00% | – |
| Q3 2019 | $2,000 | -98.9% | 200 | -96.2% | 0.00% | -100.0% |
| Q4 2016 | $184,000 | +41.5% | 5,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $130,000 | +1757.1% | 5,300 | +1666.7% | 0.00% | – |
| Q2 2016 | $7,000 | -97.3% | 300 | -97.3% | 0.00% | -100.0% |
| Q1 2016 | $264,000 | -22.6% | 11,300 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $341,000 | -24.1% | 11,300 | 0.0% | 0.01% | -28.6% |
| Q3 2015 | $449,000 | -42.4% | 11,300 | 0.0% | 0.01% | -36.4% |
| Q2 2015 | $780,000 | +26.2% | 11,300 | 0.0% | 0.01% | +22.2% |
| Q1 2015 | $618,000 | +31.8% | 11,300 | +2.7% | 0.01% | +50.0% |
| Q4 2014 | $469,000 | +33.6% | 11,000 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $351,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |